ESOT The European Society
for Organ Transplantation

What can we help you find?

Leading the way in transplantation

Filter results for:

Don't need the search bar? Close it here

Search Results for:

Inspirational Event (online) on 22 June – part of ESOT Hackathon 2021

Empowering Transplant Patients ESOT is delighted to launch the first edition of the ESOT Hackathon to identify and develop tools to serve the transplant patient community. Whether it is an idea, a scenario, a prototype, an app, an interface, a proof of concept or a turnkey solution, we are looking for innovative approaches to improve

ESOT Congress 2021 and the COVID-19 pandemic – Update 07|06|2021

Dear colleagues, With this message, we aim to provide an update on the current status of the ESOT Congress 2021 and the COVID-19 pandemic. Whilst we are still fully committed to providing an immersive hybrid congress experience with a full in-person presence, we understand that some of you are bound by travel restrictions and/or do

ESOT Equality, diversity, and inclusion survey

ESOT is committed to promoting diversity and inclusion within the society and its activities, the transplantation community at large, clinical research, and patient care.   We would like to hear from all members of the transplant community and, together, build a roadmap to greater equality, diversity and inclusion in transplantation. Complete this survey on equality,

2021 ESOT Council Elections

WARNING: If you are not up to date with your ESOT membership, you will need to renew it in order to reactivate your voting rights. To ensure that we can process your request, please renew your membership no later than: 11:00 AM CEST on Friday, 4 June 2021 (payments via credit card only) Once your membership is

EPITA Board – Call for nomination

EPITA, the European Pancreas and Islet Transplant Association, wishes to announce a call for nominations for a new Board member. The mandate of the new EPITA Board Member is 4 years (2021-2025). Given the current composition of the EPITA Board, and to ensure that all relevant specialties are represented, applications from diabetes (transplant) physicians will be